Lakomek M, Neubauer B, von der Lühe A, Hoch G, Winkler H, Schröter W
University of Göttingen, Department of Pediatrics, F.R.G.
Eur J Haematol. 1992 Aug;49(2):82-92. doi: 10.1111/j.1600-0609.1992.tb00036.x.
The defective enzymes of 54 patients with pyruvate kinase (PK) deficiency were characterized according to the recommendations of the International Committee for Standardization in Haematology (ICSH). The erythrocyte PK activity in whole blood was calculated considering the 16-fold higher activity of the reticulocyte enzyme (AR) compared to the erythrocyte enzyme (AE). The following parameters turned out to give a good correlation to the degree of haemolytic anaemia and can therefore serve as a prognostic tool: All patients with a severe course of the disease had residual erythrocyte PK activities less than 33% of the normal enzymes (percentage activity), and patients with mild haemolytic anaemia exhibited residual activity values below and above this threshold value. Studies of enzyme cooperative showed that positive cooperative or mixed cooperative phosphoenolpyruvate (PEP) binding with a predominant positive cooperative part appeared in all cases with a mild clinical course, and about one-third of the severe ones. Negative cooperativity or mixed cooperativity with predominant negative cooperative part was observed only with severe haemolytic anaemia. Furthermore, the determination of glucose-6-phosphate (G-6-P) turned out to be a good prognostic criterion, i.e. all patients with mild clinical course exhibited G-6-P-concentrations lower than 0.11 mumol/l red blood cells. In the case of patients with severe haemolytic anaemia, about 80% showed values higher than 0.11 mumol/l RBC.
根据国际血液学标准化委员会(ICSH)的建议,对54例丙酮酸激酶(PK)缺乏症患者的缺陷酶进行了表征。考虑到网织红细胞酶(AR)的活性比红细胞酶(AE)高16倍,计算了全血中的红细胞PK活性。结果表明,以下参数与溶血性贫血的程度具有良好的相关性,因此可作为一种预后工具:所有疾病病程严重的患者,其红细胞PK残余活性低于正常酶的33%(活性百分比),而轻度溶血性贫血患者的残余活性值则低于或高于该阈值。酶协同性研究表明,在所有临床病程较轻的病例以及约三分之一病程严重的病例中,均出现了正协同或混合协同磷酸烯醇丙酮酸(PEP)结合,且以正协同部分为主。仅在严重溶血性贫血中观察到负协同或混合协同且以负协同部分为主。此外,葡萄糖-6-磷酸(G-6-P)的测定结果被证明是一个良好的预后标准,即所有临床病程较轻的患者,其G-6-P浓度低于0.11μmol/l红细胞。在严重溶血性贫血患者中,约80%的患者值高于0.11μmol/l红细胞。